Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MoonLake Immunotherapeutics - Class A Ordinary Shares
(NQ:
MLTX
)
49.45
+0.12 (+0.23%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,059
Open
49.43
Bid (Size)
49.31 (1)
Ask (Size)
49.58 (2)
Prev. Close
49.33
Today's Range
48.91 - 49.68
52wk Range
35.11 - 64.98
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis
June 10, 2024
From
MoonLake Immunotherapeutics AG
Via
GlobeNewswire
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
May 16, 2024
From
MoonLake Immunotherapeutics AG
Via
GlobeNewswire
Performance
YTD
-16.97%
-16.97%
1 Month
+10.62%
+10.62%
3 Month
+23.89%
+23.89%
6 Month
-7.67%
-7.67%
1 Year
-12.72%
-12.72%
More News
Read More
MLTX Stock Earnings: MoonLake Misses EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions
April 10, 2024
From
Komodo Health
Via
Business Wire
Expert Ratings for MoonLake
November 27, 2023
Via
Benzinga
Recap: MoonLake Q3 Earnings
November 14, 2023
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test
March 11, 2024
Via
Investor's Business Daily
16 Analysts Have This to Say About MoonLake
November 07, 2023
Via
Benzinga
Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?
March 11, 2024
Via
Benzinga
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day
March 10, 2024
From
MoonLake Immunotherapeutics AG
Via
GlobeNewswire
MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024
March 04, 2024
From
MoonLake Immunotherapeutics AG
Via
GlobeNewswire
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)
February 26, 2024
From
MoonLake Immunotherapeutics AG
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 20, 2023
Via
Benzinga
Why Former Highflier MoonLake Plummeted 29% After A Recent Run
November 06, 2023
Via
Investor's Business Daily
Dow Turns Lower; EchoStar Shares Plunge
November 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 06, 2023
Via
Benzinga
Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook
November 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Arthritis-Focused MoonLake Immunotherapeutics Stock Trading Lower Today?
November 06, 2023
Via
Benzinga
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
November 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Rise; Nasdaq Gains 50 Points
November 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 06, 2023
Via
Benzinga
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
November 05, 2023
From
MoonLake Immunotherapeutics AG
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
